Meridian Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.73M Sell
6,229
-145
-2% -$147K 0.76% 34
2025
Q4
$6.85M Sell
6,374
-74
-1% -$70.8K 0.95% 27
2025
Q3
$4.92M Buy
6,448
+68
+1% +$50.6K 0.7% 40
2025
Q2
$4.97M Sell
6,380
-24
-0.4% -$18.6K 0.79% 34
2025
Q1
$5.29M Sell
6,404
-459
-7% -$382K 0.9% 33
2024
Q4
$5.3M Sell
6,863
-29
-0.4% -$24K 0.87% 32
2024
Q3
$6.11M Sell
6,892
-8
-0.1% -$7.19K 1.02% 24
2024
Q2
$6.25M Sell
6,900
-213
-3% -$170K 1.11% 24
2024
Q1
$5.53M Sell
7,113
-56
-0.8% -$39.9K 1.04% 26
2023
Q4
$4.18M Buy
7,169
+2
+0% +$1.17K 0.92% 32
2023
Q3
$3.85M Sell
7,167
-46
-0.6% -$23.7K 0.96% 28
2023
Q2
$3.38M Buy
7,213
+3
+0% +$1.26K 0.82% 31
2023
Q1
$2.48M Buy
7,210
+102
+1% +$34.4K 0.62% 44
2022
Q4
$2.6M Sell
7,108
-107
-1% -$37.9K 0.67% 41
2022
Q3
$2.33M Buy
7,215
+220
+3% +$69.7K 0.66% 37
2022
Q2
$2.27M Buy
6,995
+1,615
+30% +$485K 0.6% 44
2022
Q1
$1.54M Buy
5,380
+1,175
+28% +$302K 0.36% 63
2021
Q4
$1.16M Buy
4,205
+2
+0% +$507 0.28% 78
2021
Q3
$971K Sell
4,203
-5
-0.1% -$1.23K 0.27% 80
2021
Q2
$966K Buy
4,208
+463
+12% +$93K 0.27% 80
2021
Q1
$700K Sell
3,745
-137
-4% -$26.8K 0.23% 84
2020
Q4
$655K Sell
3,882
-42
-1% -$6.27K 0.24% 88
2020
Q3
$581K Buy
3,924
+48
+1% +$7.43K 0.25% 85
2020
Q2
$636K Buy
3,876
+918
+31% +$141K 0.29% 76
2020
Q1
$410K Buy
2,958
+350
+13% +$48.1K 0.23% 83
2019
Q4
$343K Buy
2,608
+400
+18% +$46.4K 0.14% 120
2019
Q3
$247K Buy
+2,208
New +$246K 0.11% 134
2019
Q2
Sell
-1,746
Closed -$227K 133
2019
Q1
$227K Buy
1,746
+100
+6% +$12.2K 0.17% 111
2018
Q4
$190K Buy
+1,646
New +$184K 0.15% 120

Other funds holding LLY

Meridian Wealth Advisors's LLY Position: Q1 2026 in Review

Meridian Wealth Advisors reduced its Eli Lilly (LLY) stake by 2.3% in Q1 2026, selling an estimated $147K and leaving 6,229 shares worth $5.73M. The position accounts for 0.76% of the portfolio, ranked #34.

Meridian Wealth Advisors first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. The position peaked at $6.85M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Meridian Wealth Advisors held 6,229 shares of Eli Lilly worth $5.73M as of Q1 2026.
  • Meridian Wealth Advisors sold 145 Eli Lilly shares in Q1 2026, an estimated $147K.
  • Eli Lilly made up 0.76% of Meridian Wealth Advisors's portfolio in Q1 2026, its #34 holding.
  • Meridian Wealth Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
  • Meridian Wealth Advisors's Eli Lilly position peaked at $6.85M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Meridian Wealth Advisors's 13F filing for Q1 2026, filed 11 May 2026.